| 药品通用名/英文 |
NDC号/批准号 |
商标名 |
成份名 |
剂型 |
公司/生产厂 |
上市国/产地 |
规格/包装规格 |
备注 |
操作 |
| 枸橼酸伊沙佐米胶囊 |
|
NINLARO |
Ixazomib |
capsules |
Takeda Pharma A/S |
Italy / Danimarca |
2.3 mg/3capsules/box |
|
请先登录 |
| 枸橼酸伊沙佐米胶囊 |
|
NINLARO |
Ixazomib |
capsules |
Takeda Pharma A/S |
Italy / Danimarca |
3 mg/3capsules/box |
|
请先登录 |
| 枸橼酸伊沙佐米胶囊 |
|
NINLARO |
Ixazomib |
capsules |
Takeda Pharma A/S |
Italy / Danimarca |
4 mg/3capsules/box |
|
请先登录 |
| 索立德吉胶囊 |
|
Odomzo |
sonidegib |
capsule |
Sun Pharmaceutical Industries Europe B.V |
France/Netherlands |
200 mg/10capsules/box |
|
请先登录 |
| 索立德吉胶囊 |
|
Odomzo |
sonidegib |
capsule |
Sun Pharmaceutical Industries Europe B.V |
France/Netherlands |
200 mg/30capsules/box |
|
请先登录 |
| 索立德吉胶囊 |
|
Odomzo |
sonidegib |
capsule |
Sun Pharmaceutical Industries Europe B.V |
Nederland |
200 mg/10capsules/box |
|
请先登录 |
| 索立德吉胶囊 |
|
Odomzo |
sonidegib |
capsule |
Sun Pharmaceutical Industries Europe B.V |
Nederland |
200 mg/30capsules/box |
|
请先登录 |
| 索立德吉胶囊 |
47335-303 |
ODOMZO |
sonidegib |
capsule |
Sun Pharmaceutical Industries, Inc./Patheon Inc |
USA/Canada |
200 mg/30 Capsule/bottle |
|
请先登录 |
| 伊立替康脂质体注射液 |
|
Onivyde |
liposomal |
infusion |
Les Laboratoires Servier |
UK/France |
10ml/bottle |
|
请先登录 |
| 伊立替康脂质体注射液 |
|
ONIVYDE |
liposomal |
infusion |
Les Laboratoires Servier |
France |
10ml / box / bottle |
|
请先登录 |
| 伊立替康脂质体注射液 |
15054-0043 |
ONIVYDE |
irinotecan hydrochloride |
injection |
Ipsen Biopharmaceuticals, Inc. |
USA |
43 mg/10 mL /bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
nivolumab |
infusion |
Bristol-Myers Squibb Pharma EEIG |
UK/Italy |
40 mg /4 mL/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
nivolumab |
infusion |
Bristol-Myers Squibb Pharma EEIG |
UK/Italy |
100mg /10 mL/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
nivolumab |
infusion |
Bristol-Myers Squibb Pharma EEIG |
UK/Italy |
240mg /24 mL/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
nivolumab |
infusion |
Bristol-Myers Squibb Pharma EEIG |
France/Irlande |
4 mL/40 mg/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
nivolumab |
infusion |
Bristol-Myers Squibb Pharma EEIG |
France/Irlande |
10 mL/100 mg/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
nivolumab |
infusion |
Bristol-Myers Squibb Pharma EEIG |
France/Irlande |
24 mL/240 mg/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
nivolumab |
infusion |
Bristol-Myers Squibb Pharma EEIG |
Netherlands / Ierland |
4 mL/40 mg/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
nivolumab |
infusion |
Bristol-Myers Squibb Pharma EEIG |
Netherlands / Ierland |
10 mL/100 mg/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
nivolumab |
infusion |
Bristol-Myers Squibb Pharma EEIG |
Netherlands / Ierland |
24 mL/240 mg/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
注册证号 S20180014 |
OPDIVO |
Nivolumab |
injection |
Bristol-Myers Squibb Holdings Pharma, Ltd. |
中国/USA |
40mg/4mL/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
注册证号 S20180015 |
OPDIVO |
Nivolumab |
injection |
Bristol-Myers Squibb Holdings Pharma, Ltd. |
中国/USA |
100mg/10mL/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
Nivolumab |
injection |
小野薬品工業株式会社 |
JP |
20mg/2mL/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
Nivolumab |
injection |
小野薬品工業株式会社 |
JP |
100mg/10mL/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
|
OPDIVO |
Nivolumab |
injection |
小野薬品工業株式会社 |
JP |
240mg /24 mL/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
0003-3772-11 |
OPDIVO |
nivolumab |
injection |
E.R. Squibb & Sons, L.L.C. |
USA |
40 mg/4 mL/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
0003-3774-12 |
OPDIVO |
nivolumab |
injection |
E.R. Squibb & Sons, L.L.C. |
USA |
100 mg/10 mL/bottle |
|
请先登录 |
| 纳武利尤单抗注射液 |
0003-3734-13 |
OPDIVO |
nivolumab |
injection |
E.R. Squibb & Sons, L.L.C. |
USA |
240 mg/24 mL/bottle |
|
请先登录 |
| 奈昔木单抗注射液 |
|
Portrazza |
necitumumab |
infusion |
Eli Lilly Nederland B.V/Lilly S.A. |
UK/Spain |
800mg/50ml/bottle |
|
请先登录 |
| 奈昔木单抗注射液 |
|
Portrazza |
necitumumab |
infusion |
Eli Lilly Nederland B.V |
Netherlands |
800mg/50ml/bottle |
|
请先登录 |
400-8577-888